Masoud Najafi
Title
Cited by
Cited by
Year
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
B Farhood, M Najafi, K Mortezaee
Journal of cellular physiology 234 (6), 8509-8521, 2019
1272019
Cyclooxygenase‐2 in cancer: A review
N Hashemi Goradel, M Najafi, E Salehi, B Farhood, K Mortezaee
Journal of cellular physiology 234 (5), 5683-5699, 2019
902019
The mechanisms of radiation-induced bystander effect
M Najafi, R Fardid, GH Hadadi, M Fardid
Journal of biomedical physics & engineering 4 (4), 163, 2014
712014
Cancer stem cells (CSCs) in cancer progression and therapy
M Najafi, B Farhood, K Mortezaee
Journal of cellular physiology 234 (6), 8381-8395, 2019
702019
Reduction–oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics
R Yahyapour, E Motevaseli, A Rezaeyan, H Abdollahi, B Farhood, ...
Clinical and Translational Oncology 20 (8), 975-988, 2018
652018
Tumor microenvironment: Interactions and therapy
M Najafi, NH Goradel, B Farhood, E Salehi, S Solhjoo, H Toolee, ...
Journal of cellular physiology 234 (5), 5700-5721, 2019
592019
Melatonin as an anti-inflammatory agent in radiotherapy
M Najafi, A Shirazi, E Motevaseli, AH Rezaeyan, A Salajegheh, ...
Inflammopharmacology 25 (4), 403-413, 2017
592017
Contribution of regulatory T cells to cancer: A review
M Najafi, B Farhood, K Mortezaee
Journal of cellular physiology 234 (6), 7983-7993, 2019
562019
The melatonin immunomodulatory actions in radiotherapy
M Najafi, A Shirazi, E Motevaseli, G Geraily, F Norouzi, M Heidari, ...
Biophysical Reviews 9 (2), 139-148, 2017
562017
Mechanisms of inflammatory responses to radiation and normal tissues toxicity: clinical implications
M Najafi, E Motevaseli, A Shirazi, G Geraily, A Rezaeyan, F Norouzi, ...
International journal of radiation biology 94 (4), 335-356, 2018
542018
Macrophage polarity in cancer: A review
M Najafi, N Hashemi Goradel, B Farhood, E Salehi, MS Nashtaei, ...
Journal of cellular biochemistry 120 (3), 2756-2765, 2019
532019
Mechanisms of radiation bystander and non-targeted effects: implications to radiation carcinogenesis and radiotherapy
R Yahyapour, E Motevaseli, A Rezaeyan, H Abdollahi, B Farhood, ...
Current radiopharmaceuticals 11 (1), 34-45, 2018
512018
Radiation-induced inflammation and autoimmune diseases
R Yahyapour, P Amini, S Rezapour, M Cheki, A Rezaeyan, B Farhood, ...
Military Medical Research 5 (1), 9, 2018
442018
Targeting of inflammation for radiation protection and mitigation
R Yahyapour, P Amini, S Rezapoor, A Rezaeyan, B Farhood, M Cheki, ...
Current molecular pharmacology 11 (3), 203-210, 2018
422018
Radiation protection and mitigation by natural antioxidants and flavonoids: implications to radiotherapy and radiation disasters
R Yahyapour, D Shabeeb, M Cheki, AE Musa, B Farhood, A Rezaeyan, ...
Current molecular pharmacology 11 (4), 285-304, 2018
402018
Transforming growth factor‐β signaling: Tumorigenesis and targeting for cancer therapy
A Ahmadi, M Najafi, B Farhood, K Mortezaee
Journal of cellular physiology 234 (8), 12173-12187, 2019
382019
COX-2 in radiotherapy: a potential target for radioprotection and radiosensitization
M Cheki, R Yahyapour, B Farhood, A Rezaeyan, D Shabeeb, P Amini, ...
Current molecular pharmacology 11 (3), 173-183, 2018
382018
Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy
K Mortezaee, E Salehi, H Mirtavoos‐mahyari, E Motevaseli, M Najafi, ...
Journal of cellular physiology 234 (8), 12537-12550, 2019
372019
Radioprotective effects of hesperidin on oxidative damages and histopathological changes induced by X-irradiation in rats heart tissue
A Rezaeyan, GH Haddadi, M Hosseinzadeh, M Moradi, M Najafi
Journal of Medical Physics/Association of Medical Physicists of India 41 (3 …, 2016
362016
Curcumin as an anti‐inflammatory agent: Implications to radiotherapy and chemotherapy
B Farhood, K Mortezaee, NH Goradel, N Khanlarkhani, E Salehi, ...
Journal of cellular physiology 234 (5), 5728-5740, 2019
352019
The system can't perform the operation now. Try again later.
Articles 1–20